The potential lipotoxic effect of intramyocellular triglyceride (IMTG) accumulation has been suggested to be a major component in the development of insulin resistance. Increased levels of IMTGs correlate with insulin resistance in both obese and diabetic patients, but this relationship does not exist in endurance trained (ETr) subjects. This may be, in part, related to differences in the gene expression and activities of key enzymes involved in fatty acid transport and oxidation as well as in the perodixation status of the IMTGs in obese/diabetic patients as compared with ETr subjects. Disruptions in fat and lipid homeostasis in skeletal muscle have been shown to activate protein kinase C (PKC), which acts on several downstream signalling pathways, including the insulin and the IkB kinase (IKK)/NFkB signalling pathways. Additionally, an increased peroxidation of IMTGs may reduce insulin sensitivity by increasing TNFa, which is known to increase the expression of suppressor of cytokine signalling proteins (SOCS). A common characteristic observed when activating both PKC and TNFa/SOCS3 is the inhibition of tyrosine phosphorylation of IRS-1 and subsequently an inhibition of its activation of downstream signalling molecules. These may be important players in the development of insulin resistance and understanding their activation and expression in both obese and ETr humans should assist in understanding how and why IMTGs become lipotoxic.
Introduction
Tissues other than adipose tissue, which have an increased accumulation of lipids, often exhibit cellular dysfunction. This is referred to as lipotoxicity and has been targeted as a factor contributing to insulin resistance in obese and diabetic subjects. Skeletal muscle is a site of regional fat distribution and has recently been the focus of numerous investigations due to the strong association between the level of intramyocellular triglycerides (IMTGs) accumulation and insulin resistance in obese, Type 2 diabetics and healthy subjects (for reviews, see Goodpaster 1 and Schaffer
Mechanisms of IMTG accumulation
IMTGs are situated in the cytoplasm of skeletal muscle and can be seen as small droplets near the mitochondria. 4 In obesity, the accumulation of IMTG may be a response to an increased uptake of plasma fatty acids and/or from a reduced oxidation of fatty acids by the mitochondria. Important rate limiting steps in fatty acid oxidation include the transport of fatty acids to the sarcoplasm, followed by the conversion of long-chain fatty acids to long-chain acyl-CoA. Fatty acidbinding protein (FABP) transports fatty acids from the circulation to the sarcoplasm, while carnitine palmitoyl transferase (CPT) I and II translocate the long-chain acylCoA to the mitochondria. In obese humans, the content of FABP is normal, while the activity of CPTI is reduced. 5 Additionally, in obese humans, a reduced CPTI activity is paralleled by reductions in enzymes of the Krebs cycle, electron transport chain and b-oxidation, such as citrate synthase, cytochrome c and hydroxyacyl dehydrogenase, respectively. 5 In obese subjects, as compared to lean subjects, it has been shown that under fasting conditions, a condition promoting fat oxidation and suppressing glucose oxidation, fatty acid uptakes across the leg tissues are similar, despite an increased respiratory quotient and a reduced fat oxidation.
intervention promoting the oxidation of glucose and the suppression of lipolysis, fat uptake was similar in both lean and obese subjects. However, fat oxidation by the leg tissues was suppressed in lean but not in obese subjects. 6 These results
suggest that IMTG accumulation in the skeletal muscle of obese subjects is derived more from a reduced capacity for fat oxidation, and the inflexibility of skeletal muscle to sufficiently alter substrate metabolism, than from fatty acid uptake. ETr is a condition also resulting in an accumulation of IMTGs; [7] [8] [9] however, unlike obesity it promotes both an increase in fatty acid transport and oxidation. 10 20 HSL activity is increased two-fold in humans in response to moderate-low-intensity exercise. 21 HSL protein expression is greater in oxidative as compared to glycolytic muscle fibres. 22, 23 Taken together, these results show that HSL is found in skeletal muscle and suggest a role for HSL in the mobilisation of IMTG stores by muscle contraction. Whether a difference exists in the content and activity of HSL in the skeletal muscle of obese subjects as compared to lean and/or ETr subjects is presently unknown. If results obtained from adipose and pancrease tissue are any indication, skeletal muscle HSL activity may be an important player in the development of insulin resistance. Recently, a truncated HSL protein has been found in the adipose tissue of obese subjects. 24 The shortened HSL protein had a 20% lower activity than the longer protein. Additionally, the lipolytic capacity measured in isolated adipocytes incubated with norepinephrine was 40% lower in the patients presenting the truncated HSL protein. The expression of HSL has been shown to be decreased, and IMTG contents increased, in the pancreatic-islets of C57BL/6J mice following prolonged feeding on a high-fat diet. 25 This was also paralleled with a reduced insulin secretion. After shifting the mice to a low-fat diet, these responses were reversed.
Association between insulin resistance and IMTG content
The elevated levels of FFAs in obese subjects have been suggested to be a major link between obesity and insulin resistance (for a review, see Boden 26 ). However, acute changes in plasma FFA concentrations do not immediately alter insulin sensitivity and the effect is generally seen after 2-4 h. 27, 28 This time delay suggests that the effect of FFA on insulin resistance is not direct. It has been suggested that the effect of increased FFA on insulin resistance may come from their storage as IMTGs. 28 Short-term elevation of FFAs, via the infusion of a lipid emulsion under hyperinsulinemic conditions, results in an elevation of the IMTG pool. 29 Furthermore, an increase in IMTGs has been shown in insulin-resistant obese and Type 2 diabetics, when compared with lean subjects. 3, 9 Goodpaster et al 3 found that the IMTG content, measured using a routine Oil red oil stain, correlated with insulin sensitivity in lean, obese and type 2 diabetic subjects. Perseghin et al 30 reported that IMTG, quantified using magnetic resonance spectroscopy (MRS), in offspring of Type 2 diabetic patients correlated with insulin resistance. Furthermore, it has been shown that whole-body insulin-stimulated glucose uptake was lower (3.070.4 vs 5.1 þ 0.5 mg kg À1 min À1 ) in a group of subjects with high IMTGs as compared to subjects with a low content of IMTGs. 31 Combined, these data support the notion that increased IMTG levels participate in the reduction of insulin sensitivity. However, it is important to note that the link between increased IMTG and insulin resistance is not observed in all situations. For example, ETr also results in an accumulation of IMTGs, but unlike obesity, it is paralleled with an improvement in insulin sensitivity. 32, 33 The content of IMTG also varies between skeletal muscle fibre types and is positively related with the oxidative capacity of the fibres. In both obese and lean subjects, it has been shown that the IMTG content is the greatest in the oxidative type I and the lowest in the glycolytic type II muscle fibres. 34 Interestingly, it is the oxidative type I fibres which are the most insulin sensitive. 35 When comparing the divergent conditions of obesity and ETr, an apparent inconsistency exists in the relationship between IMTG and insulin sensitivity. It has been suggested by Goodpaster et al 3 that this should not be seen as a contradiction, but more as an indication that the relationship between IMTG and insulin resistance is associated with the fatty acid oxidative capacity of the muscle. This suggests that IMTG may not directly affect insulin resistance but instead provide a source for other toxic lipid metabolites.
The potential pathways linking IMTGs with insulin resistance
Increases in long-chain acyl-CoA 36 and diacylglyerol (DAG) 37 concentrations are associated with elevated levels of triglycerides and free fatty acids. The accumulation of intracellular acyl-CoA and DAG are closely related with changes in the signalling pathways downstream of the insulin receptor, 38 which may, in part, induce a resistance to insulin. The synthesis of DAG, a metabolite of IMTG hydrolysis, has been suggested to be a signal influencing insulin resistance as it is a well-known allosteric activator of the serine kinase protein kinase C (PKC). 39, 40 The activation of PKC (especially PKC-y) can phosphorylate insulin receptor substrate-1 (IRS-1) on the serine/threonine site. As a result, the tyrosine phosphorylation of IRS-1 is inhibited, 41 which further inhibits, downstream, IRS-1-associated phosphatidylinositol 3-kinase (PI3-kinase) activity and insulin-stimulated translocation of the glucose transporter, GLUT4, to the plasma membrane 42 ( Figure 1 ). IMTG accumulation has also been associated with the activation of PKC-y 42 and PKC-e 37 and the translocation of PKC-b and PKC-d from the cytosol to the cell membrane. 43 Furthermore, decreases in the atypical isoforms, PKC-, PKC-z, PKC-l and PKC-i have also been observed. 44 As well as interfering with insulin signalling, an alteration in PKC activation may also contribute to the activation of the nuclear factor-kB (NFkB) pathway. 43 PKC may directly phosphorylate the NFkB inhibitor, IkB. 45 Phosphorylation of IkB results in a release of NFkB where it translocates from the cytosol to the nucleus 46 where it induces transcription of proinflammatory genes such as TNFa and interlukin (IL)-6. 46 The possibility that insulin resistance in human skeletal muscle was related to alterations in the DAG/PKC and the IkB kinase (IKK)/NFkB signalling pathway was investigated in healthy volunteers. 43 In these subjects, insulin resistance was induced by increasing plasma fatty acid levels, via a lipid/heparin infusion, during a euglycemic-hyperinsulinemic clamp. After 2 h of lipid infusion, the rates of insulin-stimulated glucose disposal (G Rd ) were normal and there were no changes in PKC activity or DAG mass. There was however a nonsignificant (P ¼ 0.058) three-fold increase in PKC-b and PKC-d. Additionally, there was no change in the amount of IkB-a, an inhibitor of NFkB. However, after 6 h of lipid infusion, G Rd was reduced by 43%, and PKC activity and DAG mass were increased fourfold as was the abundance of membrane-associated PKC-b and PKC-d. IkB-a was also reduced by 70%. In addition, no change in ceramide, which has been shown to be implicated in fatty acid-induced insulin resistance in cultured muscle cells, 47 was observed at either time point. These results suggest a strong relationship between fatty acid-induced insulin resistance in human skeletal muscle and alterations in the DAG/PKC and the IkB kinase (IKK)/NFkB signalling pathways, but not ceramide. A hypothetical scheme linking PKC and the NFkB pathway with insulin resistance is shown in Figure 2 . Another factor linking accumulated IMTGs with insulin resistance may be oxidative stress. Lipid accumulation in steatotic liver is associated with a phenomenon of peroxidation 48 analogous to that observed in the low-density lipoproteins (LDL) of the atherosclerotic lesion. 49 Obese subjects, when compared to normal controls, have an increased susceptibility to the oxidative stress of their can activate PKC which in turn phosphorylates IRS-1 on the serine/threonine site. As a result, the tyrosine phosphorylation of IRS-1 is inhibited, which further inhibits downstream, PI3-kinase activity and insulin-stimulated translocation of GLUT4 to the plasma membrane. The reduction in GLUT4 translocation would reduce the uptake of circulating glucose and therefore present a resistance to insulin. IMTGs, intramyocellular triglycerides; DAG, diacylglyerol; PKC, protein kinase C; IRS-1, insulin receptor substrate-1; PI3-kinase, phosphatidylinositol 3-kinase; GLUT4, glucose transporter-4.
LDL 50 and show an increase in key indices of lipid peroxidation, such as thiobarbituric acid-reactive species. 51 We have recently shown that obese subjects have an increased skeletal muscle content of 4-Hydroxynonenal (4-HNE), a by-product of lipid peroxidation, 52 as compared with lean and ETr subjects. 9 The production of lipid peroxidation by-products, such as 4-Hydroxynonenal (4-HNE) and malondialdehyde (MDA), may reduce insulin sensitivity by increasing paracrine factors, such as TNFa. Such increases in TNFa maybe a direct effect via free radical activation of NFkB, which when translocated to the nucleus may also increase the transcription of TNFa. A correlation has been shown between the increased content of 4-HNE and the concentration of TNFa in patients with renal failure, 53 while oxidative stress mediates endotoxin-induced hepatic TNF-a production in acute alcohol intoxication. 54 In obese subjects, a positive association has been shown between insulin resistance, IMTG content and skeletal muscle TNFa gene expression. 55 In the same subjects, following weight-loss surgery, a decrease in TNFa was accompanied by an increase in insulin sensitivity. Based on observations in other tissues, it is possible that peroxidation of the accumulated IMTGs in obese patients results in an increase in TNFa, and following this, the development of insulin resistance. TNFa has been shown to influence insulin resistance directly by inducing suppressor of cytokine signalling (SOCS) proteins. 56 has been shown to reduce insulin sensitivity in COS-7 cells by decreasing the insulin-induced IRS-1 tyrosine phosphorylation and its association with the p85 subunit of PI-3 kinase 56 ( Figure 2 ).
In Etr subjects, as compared to obese subjects, the ratio of 4-HNE/IMTG was significantly lower suggesting a reduced peroxidation of their IMTG stores. 9 ETr increases skeletal muscle antioxidant capacity, [57] [58] [59] Whether the exercise-induced improvement in insulin sensitivity is directly related to a reduced TNFa and SOCS-3 concentration is yet to be determined.
Effects of exercise on IMTGs and insulin resistance
It appears that ETr has a positive effect on IMTG stores, while obesity has a negative effect. A major difference between ETr and obesity is a lack of skeletal muscle contractile activity in the latter. It has been suggested that the greater muscular activity in the endurance trained subjects as well as their increased b-oxidation capacity would result in a greater turnover of IMTGs and therefore a reduced chance for their peroxidation. 9 In contrast, the reduced muscular activity and b-oxidation capacity in obese subjects would result in the accumulation of IMTGs that would be stagnant and therefore prone to peroxidation. We have recently termed these different IMTG pools as 'good' and 'bad' lipids, with the IMTG stored as an adaptation to ETr and continually utilised for energy production as the 'good lipids', while the stagnant IMTGs accumulated in the obese skeletal muscle as the 'bad lipids'. 9 Other adaptations to Etr, such as increases in the activity of antioxidant molecules (such as glutathione peroxidase (GPX) and superoxide dismutase (SOD)), 57 increases in the percentage of the highly oxidative and insulinsensitive type I muscle fibres 61, 62 as well as the increases in the b-oxidation pathway, 63, 64 would also assist with the reduced risk of lipid peroxidation and insulin resistance.
